Personalized multimutation sequencing assays have potential clinically important improvements in clinical outcome in the early detection of MRD.
No takes yet. Share an insight, caveat, or question.
Coakley et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: